Patent details

EP4003400 Title: DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 FC FUSION PROTEINS

Basic Information

Publication number:
EP4003400
PCT Application Number:
US2020043542
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP207570342
PCT Publication Number:
WO2021021647
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 FC FUSION PROTEINS
French Title of Invention:
DOSAGE POUR LA PRÉVENTION OU LE TRAITEMENT DE LA MALADIE DU GREFFON CONTRE L'HÔTE (GVHD) AVEC DES PROTÉINES DE FUSION IL-22-FC
German Title of Invention:
DOSIERUNG ZUR VORBEUGUNG ODER BEHANDLUNG VON GRAFT-VERSUS-HOST-KRANKHEIT (GVHD) MIT IL-22-FC-FUSIONSPROTEINEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
03/04/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
10/04/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
03/04/2024
Unitary Effect Registration Date:
10/04/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
24/07/2020
Grant date:
03/04/2024
EP Publication Date:
01/06/2022
PCT Publication Date:
04/02/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/04/2024
EP B1 Publication Date:
03/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/07/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/03/2024
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:
SUKUMARAN, Siddharth
Address:
United States (US)

2

Name:
KALO, Matthew
Address:
United States (US)

3

Name:
DAY, Peter William
Address:
United States (US)

4

Name:
WANG, Yehong
Address:
United States (US)

5

Name:
PECK, Melicent Clare
Address:
United States (US)

6

Name:
WONG, Chin Yat
Address:
United States (US)

7

Name:
LU, Timothy Then-Chioh
Address:
United States (US)

Priority

1

Priority Number:
201962879306 P
Priority Date:
26/07/2019
Priority Country:
United States (US)

2

Priority Number:
202062976321 P
Priority Date:
13/02/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/20; A61P 37/06; C07K 14/54; C07K 19/00;

Publication

European Patent Bulletin

1

Issue number:
202414
Publication date:
03/04/2024
Description:
Grant (B1)

2

Issue number:
202419
Publication date:
08/05/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202420
Publication date:
15/05/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages